Jonathan Hindmarsh Selected Research

Jonathan Hindmarsh Research Topics

4	Death (Near-Death Experience) 05/2022 - 01/2020
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2019
2	Vomiting 01/2022 - 01/2019
2	Nausea 01/2022 - 01/2019
2	Myasthenia Gravis 10/2020 - 04/2020
1	Hypotension (Low Blood Pressure) 07/2022
1	Dyspepsia (Indigestion) 05/2022
1	Hemorrhage 05/2022
1	Hyperthermia 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Pain (Aches) 08/2021
1	Muscle Weakness 04/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Treatment-Resistant Schizophrenia 01/2020
1	Deglutition Disorders (Dysphagia) 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020

2	AntiemeticsIBA 01/2022 - 01/2019
2	rotigotine FDA Link 08/2021 - 01/2019
1	Vasoconstrictor AgentsIBA 07/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2022
1	Esomeprazole (Nexium)FDA Link 05/2022
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	Cholinergic Antagonists (Anticholinergics)IBA 10/2020
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 10/2020
1	Cholinergic ReceptorsIBA 10/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2020
1	Neostigmine (Neostigmine Bromide)IBA 04/2020
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 04/2020
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 04/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Aripiprazole (Abilify)FDA Link 01/2020
1	Clozapine (Clozaril)FDA LinkGeneric 01/2020
1	Olanzapine (Zyprexa)FDA Link 01/2020
1	Methotrimeprazine (Levomepromazine)FDA Link 01/2019

2	Therapeutics 04/2020 - 01/2020
1	Critical Care (Surgical Intensive Care) 07/2022
1	Intravenous Administration 05/2022
1	Subcutaneous Infusions 04/2020
1	Terminal Care (Care, Terminal) 01/2020